Vasoconstrictor effects of various melatonin analogs on the rat tail artery in the presence of phenylephrine

Journal of Cardiovascular Pharmacology

Volumn 33, Issue 2, 1999, Pages 316-322

  Bucher, Bernard ^a   Gauer, François ^b   Pévet, Paul ^b   Masson Pévet, Mireille ^b  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b CNRS   (France)

Author keywords

Isolated rat tail artery; Mel(1a) mRNA; Melatonin; Melatonin antagonist; Vasoconstriction

Indexed keywords

2 IODOMELATONIN; 6 CHLOROMELATONIN; AGOMELATINE; LUZINDOLE; MELATONIN; MELATONIN RECEPTOR; MESSENGER RNA; N ACETYLTRYPTAMINE; PHENYLEPHRINE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; DRUG POTENTIATION; ISOLATED ARTERY; MALE; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TAIL ARTERY; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION;

ACETAMIDES; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ENDOTHELIUM; MALE; MELATONIN; MUSCLE, SMOOTH; NERVE ENDINGS; NOREPINEPHRINE; PERFUSION; PHENYLEPHRINE; RATS; RATS, WISTAR; RECEPTORS, CELL SURFACE; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, MELATONIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SYMPATHETIC NERVOUS SYSTEM; TAIL; TRYPTAMINES; VASOCONSTRICTION;

EID: 0032899806     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199902000-00021     Document Type: Article

References (41)

1. Rollag MD, Niswender GD. Radioimmunoassay of serum concentrations of melatonin in sheep exposed to different lighting regimens. Endocrinology 1976;98:482-9.
2. Reiter RJ. Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocrinol Rev 1991;12:151-80.
3. Goldman BD, Darrow JM. The pineal gland and mammalian photoperiodism. Neuroendocrinology 1983;37:386-96.
4. Pevet P. The role of the pineal gland in the photoperiodic control of reproduction in different hamster species. Reprod Nutr Dev 1988;28:443-58.
5. Tamarkin L, Baird CJ, Alimeida OFX. Melatonin: a coordinating signal for mammalian reproduction? Science 1985;227:714-20.
6. Cassone VM. Effects of melatonin on vertebrate circadian system. TINS 1990;13:457-64.
7. Ralph MR, Foster RG, Davis FC, Menaker M. Transplanted suprachiasmatic nucleus determines circadian period. Science 1990;247:975-8.
8. Tanaka H, Yanase M, Kanosue K, Nakayama T. Circadian variation of thermoregulatory responses during exercise in rats. Am J Physiol 1990;27:R836-41.
9. Viswanathan M, Laitinen JT, Saavedra JM. Expression of melatonin receptors in arteries involved in thermoregulation. Proc Natl Acad Sci USA 1990;87:6200-3.
10. Shibata S, Satake N, Takagi T, Usui H. Vasorelaxing action of melatonin in rabbit basilar artery. Gen Pharmacol 1989;20:677-80.
11. Weekley B. Melatonin-induced relaxation of rat aorta: interaction with adrenergic agonists. J Pineal Res 1991;11:28-43.
12. Weekley B. Pharmacologic studies on the mechanism of melatonin-induced vasorelaxation in rat aorta. J Pineal Res 1995;19:133-8.
13. Weekley B. Effects of melatonin on isolated pulmonary artery and vein; role of vascular endothelium. Pulm Pharmacol 1993;6:149-54.
14. Evans BK, Mason R, Wilson VG. Evidence for direct vasoconstrictor activity of melatonin in "pressurized" segments of isolated caudal artery from juvenile rats. Naunyn Schmiedebergs Arch Pharmacol 1992;346:362-5.
15. 4 and melatonin receptors. Br J Pharmacol 1997;121:1775-81.
16. Geary GG, Duckles SP, Krause DN. Melatonin is a direct vasoconstrictor in cerebral arteries. Soc Neurosci Abstr 1995;21:157.
17. Krause DN, Barrios VE, Duckles SP. Melatonin receptors mediate potentiation of contractile responses to adrenergic nerve stimulation in rat caudal artery. Eur J Pharmacol 1995;276:207-13.
18. 1a melatonin receptor mediates melatonin-induced vasoconstriction of rat caudal and cerebral vessels. Soc Neurosci Abstr 1996;22:1400.
19. Carneiro RCG, Toffoleto O, Cipolla-Neto J, Markus RP. Modulation of sympathetic neurotransmission by melatonin. Eur J Pharmacol 1994;257:73-7.
20. Martensson LGE, Andersson RGG, Berg G. Melatonin together with noradrenaline augments contractions of human myometrium. Eur J Pharmacol 1996;316:273-5.
21. Dubocovich ML. Melatonin receptors: are there multiple subtypes? Trends Pharmacol Sci 1995;16:50-6.
22. Reppert SM, Weaver DR, Godson C. Melatonin receptors step into the light: cloning and classification of subtypes. Trends Neurosci 1996;17:100-2.
23. Alexander SPH, Peters JA. Receptor and ion channel nomenclature. Trends Pharmacol Sci 1997;(suppl):52-3.
24. Delagrange P, Renard P, Caignard DH, Guardiola-Lemaître B. Development of melatonin analogs. In: Fraschini F, ed. The pineal gland and its hormone. New York: Plenum Press, 1995:139-53.
25. Ying SW, Rusak B, Delagrange P, Mocaër E, Renard P, Guardiola-Lemaître B. Melatonin analogues as agonists and antagonists in the circadian system and other brain areas. Eur J Pharmacol 1996;296:33-42.
26. Ting KN, Dunn WR, Davies DJ, et al. Studies on the vasoconstrictor action of melatonin and putative melatonin receptor ligands in the rat tail artery of juvenile Wistar rats. Br J Pharmacol 1997;122:1299-306.
27. Tschöpl M, Miller RC, Pelton J, Stoclet JC, Bucher B. Vasoconstrictor effects of various neuropeptide Y analogues on the rat tail artery in the presence of phenylephrine. Br J Pharmacol 1993;110:1098-104.
28. Bucher B, Ouedraogo S, Tschöpl M, Paya D, Stoclet JC. Role of the L-arginine-NO pathway and of cyclic GMP in electrical field-induced noradrenaline release and vasoconstriction in the rat tail artery. Br J Pharmacol 1992;107:976-82.
29. Chomczynski P, Sacchi N. Single step method of RNA isolation by guanidium-thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
30. El-Husseini AED, Paterson JA, Shiu RPC. Basic fibroblast growth factor (BFGF) and two of its receptors, FGFR1 and FGFR2: gene expression in rat brain during postnatal development determined by quantitative RT-PCR. Mol Cell Endocrinol 1994;104:191-200.
31. Sanger F, Niklen S, Coulson AR. DNA sequencing with chain termination inhibitors. Proc Natl Acad Sci USA 1977;74:5463-7.
32. Arunlakshana O, Schild HO. Some quantitative uses of drug antagonists. Br J Pharmacol Chemother 1959;14:48-58.
33. Wallenstein S, Zucker CL, Fleiss JL. Some statistical methods useful in circulation research. Circ Res 1980;47:1-9.
34. Satake N, Oe H, Shibata S. Vasorelaxing action of melatonin in rat isolated aorta; possible endothelial dependent relaxation. Gen Pharmacol 1991;22:1127-33.
35. Monroe KK, Watts SW. The vascular reactivity of melatonin. Gen Pharmacol 1998;30:31-5.
36. + channels and endothelial factors. Br J Pharmacol 1998;123:1533-40.
37. Mahle CD, Goggins GD, Agarwal P, Ryan E, Watson AJ. Melatonin modulates vascular smooth muscle tone. J Biol Rhythms 1997;12:690-6.
38. 125I]Iodo-5-methoxy-carbonylamino-N-acetyltryptamine: a selective radioligand for the characterization of melatonin ML2 binding sites. Eur J Pharmacol 1996;301:159-68.
39. Burnstock G. Noradrenaline and ATP as cotransmitters in sympathetic nerves. Neurochem Int 1990;17:357-68.
40. 1b melatonin receptor. Proc Natl Acad Sci USA 1995;92:8734-8.
41. Doolen S, Krause DN, Dubocovich ML, Duckles SP. Melatonin mediates two distinct responses in vascular smooth muscle. Eur J Pharmacol 1998;345:67-9.